Subject: For advocates and policymakers > Public-private partnerships
- Healthy Markets Innovation Fund
This leaflet provides a brief overview of the Healthy Markets Innovation Fund in Vietnam.
Publication date: August 2015
- Healthy Markets Project
This leaflet provides a brief overview of the Healthy Markets Project in Vietnam.
Publication date: August 2015
- Supporting Influenza Vaccine Production in Vietnam
This fact sheet describes a project that PATH is implementing in Vietnam with support from the Biomedical Advanced Research and Development Authority within the US Department of Health and Human Services. The project is supporting the enhancement of sustainable influenza vaccine production in Vietnam. PATH is providing technical assistance to various groups in Vietnam to facilitate the production and clinical evaluation of safe and effective influenza vaccines and synergizing activities with work already under way in Vietnam through the World Health Organization.
Publication date: April 2015
- Meeting the Challenge, Seizing the Opportunity: US Leadership Can Advance Global Health R&D
The sixth annual policy report from GHTC outlines actions the United States can take to reduce deaths, extend lives, and secure healthier futures by supporting research for new health tools. The report highlights the need for a comprehensive, sustainable approach to financing global health R&D.
Publication date: March 2015
Part of series: GHTC's annual policy reports
- Partnering to Create Market-Based Solutions With Measurable Impact
PATH’s pioneering work with the private sector strengthens vulnerable communities and saves lives. This overview document explains the four primary ways PATH collaborates with the private sector to bring innovation to scale and features examples of successful PATH partnership projects.
Publication date: December 2014
- Healthy Markets
This fact sheet describes the Healthy Markets project, which is designed to grow the commercial market for HIV-related goods and services to meet the needs of Vietnam's most-at-risk populations. The project offers market and consumer behavior research, policy and regulatory support, technical assistance, and private-sector engagement opportunities to encourage innovation and investment.
Publication date: August 2014
- Stabilizing the Antimalarial Drug Supply: Semisynthetic Artemisinin Could Meet up to One-Third of Global Need
Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. This fact sheet describes the cross-sector partnership PATH formed to develop a new way to produce high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply.
Publication date: July 2014
- Semisynthetic Artemisinin: Cross-Sector Partnership to Stabilize the Antimalarial Drug Supply
Artemisinin-based combination therapy is considered the gold standard treatment for malaria, but global demand has often outpaced production, and pricing has been volatile. With funding from the Bill & Melinda Gates Foundation, PATH and our partners set out to develop a new pharmaceutical manufacturing process to produce commercial volumes of high-quality, nonseasonal, and affordable artemisinin to supplement the plant-based supply. This poster, presented at the Bay Area World Malaria Day Symposium on April 25, 2014, presents key facts on malaria, the market for artemisinin, partner roles, and commercial production.
Publication date: April 2014
- Delivering Health Solutions Through Public-Private Partnerships
This report outlines the key themes and recommendations identified during three policy dialogues hosted by PATH and partners in 2013 that highlight ways for public-private partnerships to effectively develop, adapt, and deliver lifesaving health innovations to those most in need.
Publication date: January 2014
- Advancing New Technologies Against Influenza
This fact sheet highlights PATH's work to advance the development of new vaccines against influenza that are affordable and accessible for the developing world.
Publication date: October 2013
- Expanding Vaccine Solutions Against Influenza
This fact sheet highlights PATH's multifaceted approach to expanding vaccine solutions against influenza that are optimal for the developing world. It describes our efforts to advance the development of promising new influenza vaccines, gain a better understanding of influenza vaccine performance in children in low-resource countries, and help emerging-country manufacturers produce influenza vaccines for pandemic preparedness.
Publication date: October 2013
- PATH and the World Health Organization: Joining Forces to Achieve Global Health Impact
This fact sheet describes how PATH and the World Health Organization have collaborated for more than three decades to improve global health. Highlights have included developing and introducing vaccines and health technologies, creating evidence-based policies, supporting improvements in reproductive health, and building regulatory capacity in Africa.
Publication date: September 2013
- Public-Private Partnerships for Global Health: PATH's Collaborations With European Partners
This policy brief highlights the essential role that public-private partnerships play in how PATH effectively develops innovations with our European partners to overcome global health challenges. These partnerships are key to ensuring the sustainability and impact of health innovations. For further information on PATH's public-private partnerships, see Public-Private Partnerships for Global Health: How PATH Advances Technologies Through Cross-Sector Collaboration.
Publication date: June 2013
Region: North America and Europe
- Financing and Coordination of Health Research: Perspectives from Nonprofits on Accelerating Product Development and Improving Access for Low- and Middle-Income Countries
This paper is the first in a series that will demonstrate how nonprofit product development organizations work to advance research and development for poverty-related and neglected diseases and conditions in low- and middle-income countries. This series is meant to inform global policy and financing debates, including but not limited to discussions on the recommendations outlined in the 2012 report from the WHO Consultative Expert Working Group on research and development.
Publication date: May 2013
- Public-Private Partnerships for Global Health: How PATH Advances Technologies Through Cross-Sector Collaboration
This policy report highlights the essential role that public-private partnerships play in driving global health product development and offers insights into the key components of successful multi-sector partnerships led by PATH. For examples of our European public-private partnerships, see Public-Private Partnerships for Global Health: PATH's Collaborations With European Partners.
Publication date: March 2013
- Road-Mapping a Total Market Approach for Family Planning and Reproductive Health Commodity Security: Workshop Materials
To meet the challenge of sustaining reproductive health commodity security in Eastern Europe and Central Asia, the United Nations Population Fund and PATH developed workshops to increase awareness about total market approaches and develop an action plan for the region. These workshop materials are from two regional workshops that were held in April 2013. For a report describing the workshops, see Road-Mapping a Total Market Approach: Eastern Europe and Central Asia Workshops April 2013.
Author: UNFPA and PATH
Publication date: 2013
Region: Eastern Europe
- Ingredients of a Successful Public-Private Partnership: A Case Study of the Landmark Vaccine Vial Monitor Partnership
This document describes the partnership that created the vaccine vial monitor, providing a useful example to policymakers, funders, nongovernmental and multilateral organizations, and product developers of how the public and private sectors can better address today’s greatest global health needs through dynamic, long-term partnerships.
Publication date: September 2012
Region: North America and Europe
- Strengthening National Regulatory Capacity: PATH Supports Countries to Ensure Health Products Are Safe, Effective, and Swiftly Delivered
Global investments to strengthen regulatory capacity in developing countries help ensure desperately needed medical products are delivered, thereby improving health and equipping countries with the expertise and infrastructure to make important health decisions for years to come.
Publication date: July 2012
- Maximizing the Benefits of Public-Private Partnerships
This document describes PATH's approach to maximizing the availability, accessibility, and affordability of global health technologies through private-sector collaboration. This approach is critical in enabling global access of the results of our private-sector partnerships. This edition is a condensed version of the 12-page document, Bringing New Health Technologies Within Reach for Everyone. It is supported by six case studies illustrating how PATH has applied this approach to a food-fortification technology, pneumococcal vaccines, human papillomavirus screening, Japanese encephalitis vaccines, malaria vaccines, and the Uniject® prefilled injection device.
Publication date: November 2009
- Bringing New Health Technologies Within Reach for Everyone
This document describes PATH’s approach to maximizing the availability, accessibility, and affordability of technologies through private-sector collaboration. A condensed version can be found here.
Publication date: May 2009